Journal - Results from #20

Choosing First-Line Systemic Therapy for Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer January 20, 2020

Controversies with PSMA-Based Imaging and Targeted Therapy January 20, 2020

A Review of Comprehensive Bone Health Management Strategies for Men with Prostate Cancer January 20, 2020

Monitoring and Managing Toxicities in Patients with Metastatic Hormone-Sensitive Prostate Cancer January 20, 2020

Genetic Evaluation of Hereditary Prostate Cancer November 11, 2019

From the Desk of the Editor: Volume 4, Issue 3 November 5, 2019

Darolutamide: Approved For Non-Metastatic Castration-Resistant Prostate Cancer November 5, 2019

Preparing Your Practice for the New Era of Theranostics November 5, 2019

Optimizing Bone Health in Prostate Cancer August 26, 2019

From the Desk of the Editor: Volume 4, Issue 2 August 26, 2019

From the Desk of the Editor: Volume 4, Issue 1 July 2, 2019

Optimizing TURBT and Optical Diagnostics in Bladder Cancer July 2, 2019

Immuno-Oncology: The Urologist's Role June 18, 2019

From the Desk of the Editor: Volume 3, Issue 4 February 27, 2019

Update on ADT in Advanced Prostate Cancer February 27, 2019

Practice-Changing Applications of Radiology and Nuclear Medicine in Genitourinary Malignancies February 27, 2019

From the Desk of the Editor: Volume 3, Issue 3 December 4, 2018

Nephrectomy in the Era of Targeted Therapy: Takeaways from the CARMENA Trial December 4, 2018

Spacers and Prostate Radiation Therapy: What Urologists Should Know December 4, 2018

Blue Light Cystoscopy: Insights on Recurrence, Progression, and Clinical Management December 4, 2018

Page 2 of 5